Growth Metrics

China Pharma Holdings (CPHI) Intangibles (2016 - 2025)

China Pharma Holdings filings provide 16 years of Intangibles readings, the most recent being $23.7 million for Q4 2025.

  • On a quarterly basis, Intangibles rose 102.83% to $23.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $23.7 million, a 102.83% increase, with the full-year FY2025 number at $23.7 million, up 102.83% from a year prior.
  • Intangibles hit $23.7 million in Q4 2025 for China Pharma Holdings, up from $8.8 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $23.7 million in Q4 2025 to a low of $106788.0 in Q3 2022.
  • Median Intangibles over the past 5 years was $3.8 million (2023), compared with a mean of $4.6 million.
  • Biggest five-year swings in Intangibles: soared 2720.99% in 2021 and later tumbled 97.66% in 2022.
  • China Pharma Holdings' Intangibles stood at $147841.0 in 2021, then skyrocketed by 1122.59% to $1.8 million in 2022, then skyrocketed by 80.1% to $3.3 million in 2023, then soared by 259.62% to $11.7 million in 2024, then surged by 102.83% to $23.7 million in 2025.
  • The last three reported values for Intangibles were $23.7 million (Q4 2025), $8.8 million (Q3 2025), and $6.4 million (Q2 2025) per Business Quant data.